CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Roche pens $490m Astex breast cancer license deal

PartnershipPositive
AI Analysis

Summary

Roche has entered into a $490 million licensing agreement with Astex for a breast cancer therapeutic candidate. The deal represents a significant partnership in oncology drug development.

Importance:7/10
Sentiment:
0.60
licensing dealbreast cancerpartnershiponcology
Related Companies

Read the original article

Published by yahoo_finance on July 6, 2026 11:05 AM

Read Original